Director/PDMR Shareholding

Director/PDMR Shareholding

Centrica PLC

15 December 2008

Centrica plc (“Centrica”) – Directors’ and other PDMRs’ share interests

In accordance with DTR 3.1.4R, Centrica announces the following transactions in respect of its ordinary share capital of 6¹⁴/81 pence each by Directors and other Persons Discharging Managerial Responsibility (“PDMRs”).

Under the recent rights issue (the “Rights Issue”), qualifying shareholders had the right to buy

3 new Centrica shares at 160 pence per new share for every 8 existing Centrica shares held on the record date of 14 November 2008.

1 Interests in Centrica shares

On 15 December 2008, the Directors and other PDMRs acquired Centrica shares pursuant to the Rights Issue as follows:

Directors and other PDMRs	Â	Number of shares acquired in the Rights Issue* Â	Â	Total number of shares beneficially held following the Rights Issue**
Executive Directors:		Â		Â
Sam Laidlaw		158,242		647,817
Phil Bentley		249,320		1,004,410
Nick Luff		92,841		368,298
Non-Executive Directors:		Â		Â
Roger Carr		7,211		26,441
Helen Alexander		945		3,465
Mary Francis		367		3,500
Andrew Mackenzie		7,875		28,875
Paul Rayner		1,875		6,875
Paul Walsh		1,687		6,187
Other PDMRs:		Â		Â
Grant Dawson		118,767		499,612
Deryk King		79,315		334,417
Catherine May		5,496		35,747
Anne Minto		62,406		258,076
Chris Weston		51,802		251,994

*For the Executive Directors and other PDMRs, these totals include shares acquired in the Rights Issue in respect of shares held in the Share Incentive Plan (or, in the case of Deryk King, the North American Employee Share Purchase Plan) and deferred and investment shares held in the Deferred and Matching Share Scheme. Such shares will be retained in the relevant scheme, where required by the scheme rules.

**These totals include shares held in the Share Incentive Plan (or, in the case of Deryk King, the North American Employee Share Purchase Plan) and deferred and investment shares held in the Deferred and Matching Share Scheme.

2 Options and awards over Centrica shares

Options and conditional awards of shares granted to Executive Directors and other PDMRs under Centrica’s employee share schemes have been adjusted to compensate for the effect of the Rights Issue.

Centrica Investor Relations:	Â	01753 494900
		Â
Centrica Media Relations:		0845 0728001

These materials do not constitute or form a part of any offer or solicitation to purchase or subscribe for securities in the United States, Australia, Canada, the People’s Republic of China, Japan, Singapore, the Republic of South Africa or Switzerland. The Nil Paid Rights, Fully Paid Rights and New Ordinary Shares have not been and will not be registered under the United States Securities Act of 1933 (the ‘Securities Act’) or under any securities laws of any state or other jurisdiction of the United States and may not be offered, sold, taken up, exercised, resold, renounced, transferred or delivered, directly or indirectly, within the United States except pursuant to an applicable exemption from the registration requirements of the Securities Act and in compliance with any applicable securities laws of any state or applicable jurisdiction of the United States. There will be no public offer of these securities in the United States, Australia, Canada, the People’s Republic of China, Japan, Singapore, the Republic of South Africa or Switzerland.